does tirzepatide raise resting heart rate Why Zepbound Increase Rate: Mechanisms and Management Cardiovascular effects of tirzepatide -

However, the doses and indications of these medications are different

Retatrutide, a triple agonist targeting GIP, GLP-1, and glucagon receptors, represents a further step in efficacy, with 24.2% weight loss achieved within 48 weeks in phase 2 studies (13) and 29% weight loss achieved over 68 weeks in a phase 3 study (16)

3 Drug interactions with MS medications No direct pharmacokinetic interactions have been identified between semaglutide (Wegovy) and common MS disease-modifying therapies (DMTs)

' , ' ' '

A mechanistic study published in 2025 traced these changes substantially to a glucagon-driven reduction in a liver protein complex (ANGPTL3/8) that controls how the bloodstream clears triglycerides, a pathway most other cholesterol drugs do not target directly [10]